Prognostic impact of pretreatment cytogenetics in adult Philadelphia chromosome-negative acute lymphoblastic leukemia in the era of minimal residual disease-Reference-Cited by-同舟云学术

Prognostic impact of pretreatment cytogenetics in adult Philadelphia chromosome-negative acute lymphoblastic leukemia in the era of minimal residual disease

Published:2016-10-03 Issue:3 Volume:123 Page:459-467
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Issa Ghayas C.¹,Kantarjian Hagop M.²,Yin C. Cameron³,Qiao Wei⁴,Ravandi Farhad²,Thomas Deborah²,Short Nicholas J.¹,Sasaki Koji²,Garcia-Manero Guillermo²,Kadia Tapan M.²,Cortes Jorge E.²,Daver Naval²,Borthakur Gautam²,Jain Nitin²,Konopleva Marina²,Khouri Issa⁵,Kebriaei Partow⁵,Champlin Richard E.⁵,Pierce Sherry²,O’Brien Susan M.⁶^ORCID,Jabbour Elias²

Affiliation:

1. Division of Cancer Medicine; The University of Texas MD Anderson Cancer Center; Houston Texas

2. Department of Leukemia; The University of Texas MD Anderson Cancer Center; Houston Texas

3. Department of Hematopathology; The University of Texas MD Anderson Cancer Center; Houston Texas

4. Department of Biostatistics; The University of Texas MD Anderson Cancer Center; Houston Texas

5. Department of Stem Cell Transplantation; The University of Texas MD Anderson Cancer Center; Houston Texas

6. Chao Family Comprehensive Cancer Center; University of California Irvine; Orange California

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.30376/fullpdf

Reference24 articles.

1. Genetic variegation of clonal architecture and propagating cells in leukaemia;Anderson;Nature.,2011

2. Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial;Sive;Br J Haematol.,2012

3. UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia;Fielding;Blood.,2014

4. Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study;Topp;Lancet Oncol.,2015

5. Inotuzumab ozogamicin, an anti-CD22-calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study;Kantarjian;Lancet Oncol.,2012

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting relapse in acute lymphoblastic leukemia;Leukemia & Lymphoma;2024-08-31

2. Impact of additional cytogenetic aberrations at diagnosis on prognosis of adults patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic hematopoietic cell transplantation: a retrospective analysis;Annals of Hematology;2024-07-04

3. Impact of Additional Cytogenetic Aberrations at Diagnosis on Prognosis of Adults Patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation：A Retrospective Analysis;2024-04-25

4. A robust and validated integrated prognostic index for defining risk groups in adult ALL: A EWALL collaborative study.;Blood Advances;2023-12-19

5. Novel strategies to prevent and overcome relapse after allogeneic hematopoietic cell transplantation in acute lymphoblastic leukemia;Frontiers in Immunology;2023-06-08